Skip to content

Health— page 3

health

Health Rounds: AstraZeneca drug reduces lung disease flare-ups in late-stage trials

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By Nancy Lapid Sept 9 (Reuters) – Today we feature data from studies being presented at the ongoing European Respiratory Society Congress in Barcelona. EXPERIMENTAL DRUG REDUCES L

· SRN Health
Health Rounds: AstraZeneca drug reduces lung disease flare-ups in late-stage trials
health

Bangladesh fights world’s worst measles outbreak as vaccination gaps fuel spread

By Ruma Paul DHAKA, Sept 9 (Reuters) – Bangladesh, which once came close to eliminating measles, is facing its worst outbreak on record, with 999 suspected and confirmed measles-related deaths reported since March as hospitals struggle with overcrowding, shortages and a continuing influx of sick chi

· SRN Health
Bangladesh fights world’s worst measles outbreak as vaccination gaps fuel spread
health

Tylenol use in pregnancy may be linked with uterus, ovary changes in daughters

By Nancy Lapid Sept 9 (Reuters) – Female reproductive organ development may be impacted by a mother’s use of Tylenol during pregnancy, according to researchers who emphasize that their study does not prove the pain medicine is to blame and does not indicate any effect on the girls’ future fertility.

· SRN Health
Tylenol use in pregnancy may be linked with uterus, ovary changes in daughters
health

Report says Australian study finds 31 rugby league players with brain disease CTE

SYDNEY (AP) — A study has found 31 rugby league players in Australia have been diagnosed with the degenerative brain disease chronic traumatic encephalopathy (CTE), the Australian Broadcasting Corp. reported. The ABC reported Australian Sports Brain Bank findings that showed players in their 20s, 30

· SRN Health
Report says Australian study finds 31 rugby league players with brain disease CTE
health

Evommune scraps eczema drug after trial miss, shares plunge

Sept 8 (Reuters) – Evommune said on Tuesday it will not advance its experimental skin disease drug after it failed to meet the main goal in a mid-stage trial, sending its shares down 24% in aftermarket trading. Here are some details • The company said its drug, EVO756, did not show a meaningful perc

· SRN Health
health

Blackstone explores sale of ZO Skin Health, sources say

By Abigail Summerville NEW YORK, Sept 8 (Reuters) – Investment firm Blackstone is looking to sell medical-grade skincare company ZO Skin Health, which could be valued at around $2 billion in any deal, according to people familiar with the matter. The firm is working with investment bankers at Citigr

· SRN Health
Blackstone explores sale of ZO Skin Health, sources say
health

Amgen-AstraZeneca lung cancer drug combo boosts survival in late-stage trial

Sept 8 (Reuters) – Amgen’s targeted immunotherapy, Imdelltra, combined with AstraZeneca’s cancer drug Imfinzi, significantly improved overall survival in patients with extensive-stage small-cell lung cancer in a late-stage trial, the companies said on Tuesday. Here are some details: • The trial test

· SRN Health
Amgen-AstraZeneca lung cancer drug combo boosts survival in late-stage trial
health

AI healthcare platform Forus valued at $3 billion in latest funding round

Sept 8 (Reuters) – AI healthcare platform Forus said on Tuesday it has raised $150 million in a funding round that valued the company at $3 billion, tripling its valuation in about four months. Here are more details: • The Series C round was led by Bain Capital Ventures, which has backed Forus since

· SRN Health
health

Pharvaris’ genetic disorder drug meets main goal in late-stage trial

By Kunal Das Sept 8 (Reuters) – Pharvaris said on Tuesday its experimental oral drug helped prevent swelling attacks in patients with hereditary angioedema, meeting the main goal of a late-stage trial. Shares of the company were up more than 15% in early trading. • Hereditary angioedema is a rare ge

· SRN Health
health

Bristol Myers’ blood cancer cell therapy succeeds in mid-stage trial

Sept 8 (Reuters) – Bristol Myers Squibb said on Tuesday its experimental cell therapy showed a high overall response rate in a mid-stage trial, in patients with a hard-to-treat form of blood cancer. The study evaluated the therapy, called arlocabtagene autoleucel, or arlo-cel, in patients with advan

· SRN Health
Bristol Myers’ blood cancer cell therapy succeeds in mid-stage trial
health

Roivant’s experimental lung disease drug meets goals in mid-stage study

By Sahil Pandey Sept 8 (Reuters) – Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients with high blood pressure associated with a type of lung disease, sending shares up about 17%. Roivant has been expanding its late-stage pipeline after winning U.S. app

· SRN Health
health

WHO says staff shortage, funding challenges hamper Congo Ebola response

By Olivia Le Poidevin GENEVA, Sept 8 (Reuters) – Shortages of trained staff, operational partners and funding are causing a bottleneck in efforts to expand the Ebola response in the Democratic Republic of Congo as the outbreak spreads geographically, a World Health Organization official said on Tues

· SRN Health
WHO says staff shortage, funding challenges hamper Congo Ebola response
health

Novartis twin drug setbacks pile pressure on pipeline, CEO

By Bhanvi Satija, Dave Graham and Marleen Kaesebier ZURICH, Sept 8 (Reuters) – Novartis said on Tuesday its experimental drug for a muscle-wasting disorder failed a late-stage study, the second major trial setback in days and sending the Swiss drugmaker’s shares down about 9% in one of its worst tra

· SRN Health
Novartis twin drug setbacks pile pressure on pipeline, CEO
health

Sandoz focuses on biosimilars to help double group sales by 2035

By Bhanvi Satija and Marleen Kaesebier LONDON, Sept 8 (Reuters) – Swiss drug maker Sandoz is switching focus to biosimilars as it shifts away from generics and aims to more than double group net sales by 2035, the company said at its capital markets day on Tuesday. “Our Bio100 ambitions are set to p

· SRN Health
health

Cyclospora outbreak followed years of declining FDA foreign inspections

WASHINGTON (AP) — A nationwide outbreak of cyclospora tied to contaminated lettuce has heightened safety concerns about imported food, while underscoring a longer-term trend: U.S. regulators are conducting fewer international inspections to catch contaminated produce before it lands on American plat

· SRN Health
Cyclospora outbreak followed years of declining FDA foreign inspections
health

Nepal holds a day of mourning after floods kill at least 1,300 people

KATHMANDU, Nepal (AP) — Nepal held a day of mourning Monday to remember those killed in the Aug. 26 floods, with flags lowered at government offices and families concluding mourning rituals. Monday was the 13th day since the flooding which killed more than 1,300 people in Nepal and Tibet and left so

· SRN Health
Nepal holds a day of mourning after floods kill at least 1,300 people
health

Husband of Tanzania’s president dies while undergoing hospital treatment

DAR ES SALAAM, Tanzania (AP) — The husband of Tanzania’s President Samia Suluhu Hassan died Monday while undergoing treatment in a hospital in Zanzibar, the country’s vice president said. Hafidh Ameir Hassan became Tanzania’s first gentleman in 2021, when his wife took office as the country’s first

· SRN Health
Husband of Tanzania’s president dies while undergoing hospital treatment
health

Novo scraps two more heart drug trials, further dimming growth beyond obesity

By Patrick Wingrove Sept 7 (Reuters) – Novo Nordisk said on Monday it had halted two additional trials of its experimental cardiovascular drug ziltivekimab, further denting the Danish drugmaker’s efforts to diversify beyond its blockbuster obesity and diabetes franchise. In July, Novo said ziltiveki

· SRN Health
Novo scraps two more heart drug trials, further dimming growth beyond obesity
health

Novo Nordisk says semaglutide cut obesity rates in young children in trial

COPENHAGEN, Sept 7 (Reuters) – Novo Nordisk said on Monday that in a late-stage trial, 40.4% of children aged 6 to under 12 treated with semaglutide, the active ingredient in its blockbuster weight-loss drug Wegovy, were no longer classified as having obesity after 68 weeks, assuming full adherence

· SRN Health
Novo Nordisk says semaglutide cut obesity rates in young children in trial
health

Novartis cholesterol setback tests hopes for emerging heart disease drugs

By Bhanvi Satija LONDON, Sept 7 (Reuters) – Shares of Novartis fell more than 3% on Monday after its cholesterol drug failed in a closely watched study, dealing a blow to what investors had seen as a blockbuster treatment and raising pressure on upcoming data from a muscle-wasting therapy acquired t

· SRN Health
Novartis cholesterol setback tests hopes for emerging heart disease drugs
health

Indian health activists lodge concerns about food warning proposal in court

By Aditya Kalra NEW DELHI, Sept 7 (Reuters) – Indian activists spearheading calls for food labelling said a government proposal to have red warnings only when two concerning nutrients are high created an “industry-friendly loophole” disregarding public health, marking the first formal court objectio

· SRN Health
Indian health activists lodge concerns about food warning proposal in court
health

Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump

Sept 7 (Reuters) – Bubs Australia said on Monday it secured permanent authorisation from the U.S. Food and Drug Administration to sell three infant formula products in the country, sending its shares up 30% to their highest close since mid-February. Here are the details: • The stock surged as much a

· SRN Health
health

Congo’s Ebola burial teams battle community anger, fatigue and fear of infection

BUNIA, Congo (AP) — Yuma Adolphe and his team are responsible for the safe and dignified burial of some of the people who die from Ebola in Congo’s Ituri province, the epicenter of history’s deadliest Ebola outbreak. Nearly every day, they dig the graves, prepare the bodies and handle the coffins. B

· SRN Health
Congo’s Ebola burial teams battle community anger, fatigue and fear of infection
health

Bangladesh dengue outbreak accelerates as hospitals come under strain

By Ruma Paul DHAKA, Sept 6 (Reuters) – Bangladesh’s dengue outbreak is accelerating, with 42,590 people hospitalised and 117 deaths recorded this year, as a sharp September surge strains hospitals and raises fears the mosquito-borne disease could intensify further in the coming weeks. At least four

· SRN Health
Bangladesh dengue outbreak accelerates as hospitals come under strain